VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ALLO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ALLOAllogene Therapeutics, Inc.
$0.70$240M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksALLOQuarterly Balance Sheet

Allogene Therapeutics, Inc. (ALLO) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Allogene Therapeutics, Inc. (ALLO) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

ALLO Balance Sheet

Quarterly statement

ALLO Balance Sheet

Allogene Therapeutics, Inc. (ALLO) balance sheet — 9-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets299.83M340M273.29M257.75M260.72M282.65M291.58M303.39M304.42M457.12M395.36M459.12M473.45M502.1M481.46M528.82M569.06M513.03M469.74M471.32M
Cash & Short-Term Investments292.96M332.6M266.89M250.21M252.19M273.12M280.04M292.48M291.56M444.63M384.86M448.7M465.5M491.96M471.22M517.32M552.23M490.49M449.05M457.3M
Cash Only29.27M38.63M30.31M51.69M37.81M52.33M42.45M75.22M51.24M170.67M51.04M83.16M69.25M154.76M109.93M61.9M74.36M96.04M84.51M173.31M
Short-Term Investments263.69M293.98M236.58M198.52M214.38M220.79M237.59M217.26M240.32M273.96M333.82M365.54M396.26M337.2M361.29M455.42M477.87M394.45M364.54M283.99M
Accounts Receivable001.3M1.5M2.1M00002M1.7M01.6M0000000
Days Sales Outstanding----------7.03K-6.69K-------
Inventory000000000000-1.6M0000000
Days Inventory Outstanding--------------------
Other Current Assets005.11M6.04M6.42M9.54M11.53M10.91M12.85M10.5M010.42M7.95M10.14M10.24M11.5M0000
Total Non-Current Assets211.49M210.09M122.67M158.16M179.05M187.94M216.41M245.32M284.7M189.76M190.99M183.72M238.87M268.87M265.41M292.75M318.51M434.62M494.89M579.5M
Property, Plant & Equipment101.46M105.12M108.84M112.73M116.83M120.82M127.07M131.26M135.3M150.47M160.41M163.18M181.47M186.7M191.81M196.43M199.69M204.05M177.26M181.02M
Fixed Asset Turnover-0.04x--------0.00x-0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments95.92M90.99M10.29M8.04M35.24M29.51M55.51M80.67M111.82M11.43M25.41M3.65M47.83M62.5M53.91M76.47M99.15M211.33M298.3M382.38M
Other Non-Current Assets14.12M13.98M3.53M37.39M26.98M37.6M33.83M33.39M37.58M27.87M5.16M16.9M9.58M19.67M19.68M19.86M19.67M19.23M19.33M16.11M
Total Assets511.32M550.09M395.96M415.9M439.77M470.59M507.98M548.71M589.12M646.88M586.35M642.84M712.33M770.97M746.87M821.58M887.57M947.64M964.63M1.05B
Asset Turnover-0.01x--------0.00x-0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
Asset Growth %16.27%16.89%-22.05%-24.2%-25.35%-27.25%-13.37%-14.64%-17.3%-16.1%-21.49%-21.76%-19.74%-18.64%-22.57%-21.82%-17.76%-15.89%-18.19%-14.42%
Total Current Liabilities38.5M31.73M28.33M32.51M31.83M31.68M30.02M35.52M32.57M37.3M30.89M37.08M37.64M54.72M59.59M53.73M48.87M44.91M36.88M47.91M
Accounts Payable8.78M5.96M4.93M4.27M3.7M4.85M5.06M5.39M5.51M12.94M5.78M5.9M6.21M10.23M14.69M13.89M11.04M9.71M8.71M10.26M
Days Payables Outstanding----------149.44-211.64-------
Short-Term Debt008.42M08.01M00007.22M6.93M06.58M0000000
Deferred Revenue (Current)000000000086K86K236K229K273K95K889K836K406K156K
Other Current Liabilities0014.98M10.24M20.04M0012.15M0-7.22M-6.93M12.66M-6.58M0017.93M00016.13M
Current Ratio7.79x10.72x9.65x7.93x8.19x8.92x9.71x8.54x9.35x12.25x12.80x12.38x12.58x9.18x8.08x9.84x11.64x11.42x12.74x9.84x
Quick Ratio7.79x10.72x9.65x7.93x8.19x8.92x9.71x8.54x9.35x12.25x12.80x12.38x12.62x9.18x8.08x9.84x11.64x11.42x12.74x9.84x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities80.27M82.19M88.75M90.85M92.61M94.36M92.57M91.01M92.8M94.54M94.09M93.53M91.59M93.34M95.02M100.97M98.74M100.79M72.53M77.72M
Long-Term Debt00000000000000000000
Capital Lease Obligations68.04M70.35M72.63M75.05M77.13M79.24M81.29M83.25M85.14M86.99M88.92M88.35M90.1M91.82M93.51M95.12M96.71M98.23M69.03M69.93M
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities12.23M11.84M16.12M15.8M15.47M15.12M11.28M7.76M7.67M7.55M5.17M5.18M1.49M1.52M1.51M5.85M2.03M2.55M3.49M7.79M
Total Liabilities118.77M113.92M117.08M123.36M124.44M126.03M122.59M126.53M125.37M131.84M124.98M130.6M129.22M148.06M154.61M154.7M147.61M145.69M109.4M125.63M
Total Debt68.04M70.35M81.05M83.25M85.14M79.24M81.29M90.76M85.14M94.21M95.85M95.12M96.68M91.82M99.7M101.12M96.71M98.23M69.03M73.13M
Net Debt38.77M31.73M50.74M31.57M47.33M26.91M38.84M15.54M33.9M-76.46M44.81M11.97M27.43M-62.94M-10.23M39.22M22.35M2.19M-15.48M-100.19M
Debt / Equity0.17x0.16x0.29x0.28x0.27x0.23x0.21x0.21x0.18x0.18x0.21x0.19x0.17x0.15x0.17x0.15x0.13x0.12x0.08x0.08x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage-131.90x-123.42x-141.02x-122.99x-119.35x-189.09x-397.22x-733.52x-661.93x-----------
Total Equity392.55M436.18M278.88M292.54M315.33M344.56M385.39M422.18M463.75M515.04M461.37M512.23M583.1M622.91M592.26M666.88M739.96M801.95M855.23M925.2M
Equity Growth %24.49%26.59%-27.64%-30.71%-32%-33.1%-16.47%-17.58%-20.47%-17.32%-22.1%-23.19%-21.2%-22.33%-30.75%-27.92%-23.71%-21.67%-20.06%-14.3%
Book Value per Share1.131.331.161.331.421.571.792.002.222.712.733.043.484.244.104.635.155.596.056.65
Total Shareholders' Equity392.55M436.18M278.88M292.54M315.33M344.56M385.39M422.18M463.75M515.04M461.37M512.23M583.1M622.91M592.26M666.88M739.96M801.95M855.23M925.2M
Common Stock346K345K245K229K223K220K219K212K210K209K170K169K168K167K146K144K144K144K143K142K
Retained Earnings-2.15B-2.1B-2.05B-2.01B-1.97B-1.93B-1.88B-1.82B-1.76B-1.69B-1.63B-1.56B-1.47B-1.41B-1.33B-1.23B-1.14B-1.06B-983.2M-894.55M
Treasury Stock00000000000000000000
Accumulated OCI-1.44M-518K-183K269K235K-45K43K-89K157K-780K-927K-955K-2.41M-3.85M-5.93M-9.93M-12.96M-11.47M-9.25M-2.57M
Minority Interest00000000000000000000